Novel compositions for the treatment of IRDS and ARDS are indicated which contain N-(3,5-dichloro-pyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethox- ybenzamide and/or its pharmacologically tolerable salts and lung surfactant.
RELATED APPLICATION
This application is a divisional of application Ser. No. 09/369,455, filed Aug. 6, 1999, now U.S. Pat. No. 6,436,970, which is a continuation of PCT/EP98/00847, filed Feb. 14, 1998, which claims priority to German application 19705924.4, filed Feb. 17, 1997 and EPO 97102639.8, filed Feb. 19, 1997.
Priority Data
Feb 17, 1997 [DE] 197 05 924 Feb 19, 1997 [EP] 97102639
